MiR-26a and miR-26b mediate osteoarthritis progression by targeting FUT4 via NF-κB signaling pathway

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Osteoarthritis (OA) is a prevalent joint disease marked by cartilage degradation.
• MicroRNAs (miRNAs) are implicated as key regulators in OA pathogenesis.
• Understanding molecular mechanisms is crucial for developing effective OA treatments.

Purpose of the Study:

• To investigate the role of miR-26a/26b in human chondrocytes.
• To determine the interaction between miR-26a/26b and fucosyltransferase 4 (FUT4).
• To elucidate the involvement of the NF-κB signaling pathway in OA pathogenesis mediated by miR-26a/26b and FUT4.

Main Methods:

• Differential expression analysis of FUT4 and miR-26a/26b in OA patient cartilage.
• Luciferase reporter assay to confirm miR-26a/26b targeting of FUT4.
• In vitro studies on chondrocyte proliferation, apoptosis, and extracellular matrix degradation.
• In vivo studies using an OA mouse model with intra-articular miR-26a/26b injection.
• Analysis of NF-κB signaling pathway activity.

Main Results:

• miR-26a/26b and FUT4 expression were altered in OA cartilage.
• miR-26a/26b directly targets FUT4 in chondrocytes.
• miR-26a/26b and FUT4 modulated IL-1β-induced extracellular matrix degradation.
• Overexpression of miR-26a/26b reduced chondrocyte apoptosis and enhanced proliferation.
• miR-26a/26b overexpression attenuated OA progression in mice.
• The miR-26a/26b/FUT4 axis regulated NF-κB pathway activity.

Conclusions:

• The miR-26a/26b/FUT4 axis plays a significant role in chondrocyte biology and OA.
• This pathway influences extracellular matrix integrity and inflammatory responses.
• miR-26a/26b demonstrates therapeutic potential for osteoarthritis.
• The miR-26a/26b/FUT4/NF-κB axis represents a promising target for OA treatment.